Neuromyelitis optica and myotonic dystrophy type 2: a rare association with diagnostic implications
- 9 July 2020
- journal article
- letter
- Published by Springer Science and Business Media LLC in Zeitschrift für Neurologie
- Vol. 267 (9), 2744-2746
- https://doi.org/10.1007/s00415-020-10049-5
Abstract
No abstract availableThis publication has 15 references indexed in Scilit:
- White matter hyperintensities in myotonic dystrophy type 2: Not always another expression of the diseaseMultiple Sclerosis and Related Disorders, 2018
- Autoimmune aquaporin-4 induced damage beyond the central nervous systemMultiple Sclerosis and Related Disorders, 2017
- Fatigue in patients with neuromyelitis optica spectrum disorder and its impact on quality of lifePLOS ONE, 2017
- Neuromyelitis Optica in a Patient from Family with both Myotonic Dystrophy Type 1 and 2Journal of Neuromuscular Diseases, 2017
- Pain in neuromyelitis optica—prevalence, pathogenesis and therapyNature Reviews Neurology, 2014
- The Coexistence of Myasthenia Gravis and Myotonic Dystrophy Type 2 in a Single PatientJournal of Clinical Neurology, 2013
- Absence of Glial α-Dystrobrevin Causes Abnormalities of the Blood-Brain Barrier and Progressive Brain EdemaOnline Journal of Public Health Informatics, 2012
- Strong association between myotonic dystrophy type 2 and autoimmune diseasesJournal of Neurology, Neurosurgery & Psychiatry, 2009
- Differential targeting of nNOS and AQP4 to dystrophin-deficient sarcolemma by membrane-directed α-dystrobrevinJournal of Cell Science, 2008
- Revised diagnostic criteria for neuromyelitis opticaNeurology, 2006